News by Subject Biology

Researchers from the University of Freiburg are mapping the distribution of all proteins in mitochondria for the first time.

In collaboration with teams from the Czech Republic and Japan, researchers from the Institut Pasteur, (AP-HP), and (AP-HM) have identified the likely origin of the cross-reactivity between cypress pollen, peaches and citrus fruits. Their work has shown that these sources contain allergens belonging to a new family of proteins involved in pollen food associated syndrome. This discovery, published in JACI on Aug. 3, paves the way for the development of novel allergy diagnostic tests.

OIST researchers improve perovskite-based technology in the entire energy cycle, from solar cells harnessing power to LED diodes to light the screens of future electronic devices and other lighting applications.

A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease.

A new study suggests it may be possible to slow dangerous infections by manipulating the messages microbes send to one another, allowing the body to defeat an infection without causing the bacteria to develop resistance to the treatment.

Scientists are increasingly appreciating estrogen's role in brain health. The latest research from Hiroshima University connecting DHA synthesis to estrogen production, and consequentially brain health, backs up further the old adage that a daily intake of fish oil is good for you.

NPGL, a recently discovered protein involved in brain signalling, has been found to increase fat storage by the body -- even when on a low-calorie diet. In addition, NPGL was shown to increase appetite in response to high caloric food intake, suggesting that perhaps we shouldn't feel so guilty about gorging on junk food from time to time.

New findings challenge existing dogma that neurons release fixed amounts of chemical signal at any one time and could have implications for brain disorders including Parkinson's and schizhophrenia.

Treatment of tuberculosis involves a combination of several drugs, sometimes including drugs from a class known as fluoroquinolones. Using computer simulations, scientists have shown that the fluoroquinolone known as moxifloxacin may be superior to two other commonly used fluoroquinolones, according to a new paper in PLOS Computational Biology.